When did LEMAITRE VASCULAR INC (LMAT) report earnings last quarter?
LEMAITRE VASCULAR INC (LMAT) last reported earnings on 2/25/2026.
NASDAQ:LMAT • US5255582018
Past quarterly earnings results for LEMAITRE VASCULAR INC (LMAT), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.68 | 0.68 | 0.42% | 38.78% | 64.453M | 64.079M | 0.58% | 15.68% |
| Q3 2025 | 0.62 | 0.58 | 7.38% | 26.53% | 61.046M | 63.417M | -3.74% | 11.36% |
| Q2 2025 | 0.60 | 0.58 | 3.81% | 15.38% | 64.232M | 63.729M | 0.79% | 15.01% |
| Q1 2025 | 0.48 | 0.51 | -5.52% | 9.09% | 59.871M | 58.795M | 1.83% | 11.95% |
| Q4 2024 | 0.49 | 0.50 | -2.50% | 28.95% | 55.717M | 57.077M | -2.38% | 13.98% |
| Q3 2024 | 0.49 | 0.44 | 10.43% | 48.48% | 54.819M | 54.573M | 0.45% | 15.63% |
| Q2 2024 | 0.52 | 0.48 | 8.14% | 44.44% | 55.849M | 56.086M | -0.42% | 11.44% |
| Q1 2024 | 0.44 | 0.39 | 11.39% | 62.96% | 53.478M | 52.536M | 1.79% | 13.60% |
| Q4 2023 | 0.38 | 0.36 | 4.29% | 52.00% | 48.883M | 50.002M | -2.24% | 19.37% |
| Q3 2023 | 0.33 | 0.31 | 6.95% | 32.00% | 47.411M | 48.531M | -2.31% | 21.47% |
| Q2 2023 | 0.36 | 0.32 | 11.54% | 125.00% | 50.115M | 49.053M | 2.17% | 19.01% |
| Q1 2023 | 0.27 | 0.26 | 5.28% | - | 47.075M | 44.411M | 6.00% | 19.00% |
| Q4 2022 | 0.25 | 0.26 | -5.21% | -10.71% | 40.95M | 41.812M | -2.06% | 3.67% |
| Q3 2022 | 0.25 | 0.28 | -11.68% | -16.67% | 39.03M | 40.861M | -4.48% | 1.72% |
| Q2 2022 | 0.16 | 0.27 | -40.81% | -60.00% | 42.11M | 42.276M | -0.39% | 3.54% |
| Q1 2022 | 0.27 | 0.28 | -4.49% | -3.57% | 39.56M | 39.426M | 0.34% | 10.26% |
| Q4 2021 | 0.28 | 0.31 | -10.36% | -17.65% | 39.5M | 40.494M | -2.45% | 5.19% |
| Q3 2021 | 0.30 | 0.33 | -9.50% | -18.92% | 38.37M | 39.827M | -3.66% | 5.35% |
| Q2 2021 | 0.40 | 0.35 | 15.91% | 90.48% | 40.67M | 39.73M | 2.37% | 63.66% |
| Q1 2021 | 0.28 | 0.28 | 1.05% | 75.00% | 35.88M | 35.902M | -0.06% | 17.45% |
| Q4 2020 | 0.34 | 0.30 | 13.64% | - | 37.55M | 36.292M | 3.47% | - |
| Q3 2020 | 0.37 | 0.20 | 86.98% | - | 36.42M | 32.25M | 12.93% | - |
| Q2 2020 | 0.21 | 0.01 | 2,986.69% | - | 24.85M | 17.468M | 42.26% | - |
| Q1 2020 | 0.16 | 0.16 | 2.30% | - | 30.55M | 30.778M | -0.74% | - |
Notes
LEMAITRE VASCULAR INC (LMAT) last reported earnings on 2/25/2026.
LEMAITRE VASCULAR INC (LMAT) beat EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, LEMAITRE VASCULAR INC (LMAT) has beaten EPS estimates in 3 out of 4 releases.